GL1X · GenesisL1 explorer

Research workbench

Crystal structure of JAK2 in complex with peficitinib

Analyse Crystal structure of JAK2 in complex with peficitinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AAJ
Type
protein
Length
557 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase JAK2
EC
2.7.10.2
UniProt
O60674
Ligands
9T6
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase JAK2 (EC 2.7.10.2)protein28343% helix, 18% strandO60674
BTyrosine-protein kinase JAK2 (EC 2.7.10.2)protein27445% helix, 18% strandO60674

Ligands and binding sites

  • 9T6 · 4-[[(1S,3R)-5-oxidanyl-2-adamantyl]amino]-1H-pyrrolo[2, 3-b]pyridine-5-carboxamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19900.740.7771empty
24400.690.81559T6
32430.690.85259T6
41030.360.7431empty
5790.330.7522empty

Interfaces

1 interface between chains.

  • A–B · 437 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 modified (phosphorylation).

Compared structures

  • 6AAJ · Crystal structure of JAK2 in complex with peficitinib · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.